STAAR Surgical (STAA) Competitors

Haemonetics (NYSE:HAE) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.

Which has more risk and volatility, HAE or STAA?

Haemonetics has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.

Do analysts recommend HAE or STAA?

Haemonetics currently has a consensus price target of $101.22, suggesting a potential upside of 73.71%. STAAR Surgical has a consensus price target of $25.29, suggesting a potential upside of 53.06%. Given Haemonetics' stronger consensus rating and higher probable upside, research analysts plainly believe Haemonetics is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.78
STAAR Surgical	1 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has better earnings and valuation, HAE or STAA?

Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.37B	2.13	$117.56M	$2.54	22.94
STAAR Surgical	$313.90M	2.60	-$20.21M	-$0.41	-40.29

Do institutionals & insiders hold more shares of HAE or STAA?

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 1.8% of Haemonetics shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community believe in HAE or STAA?

Haemonetics received 112 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 61.60% of users gave Haemonetics an outperform vote while only 54.22% of users gave STAAR Surgical an outperform vote.

Company	Underperform	Outperform
Haemonetics	Outperform Votes 401 61.60%	Underperform Votes 250 38.40%
STAAR Surgical	Outperform Votes 289 54.22%	Underperform Votes 244 45.78%

Is HAE or STAA more profitable?

Haemonetics has a net margin of 9.47% compared to STAAR Surgical's net margin of -6.44%. Haemonetics' return on equity of 23.66% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	9.47%	23.66%	8.82%
STAAR Surgical	-6.44%	-3.35%	-2.67%

Does the media favor HAE or STAA?

In the previous week, STAAR Surgical had 7 more articles in the media than Haemonetics. MarketBeat recorded 14 mentions for STAAR Surgical and 7 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.26 beat STAAR Surgical's score of 1.09 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Haemonetics beats STAAR Surgical on 16 of the 19 factors compared between the two stocks.